Mikael Svensson

14PUBLICATIONS
23CO-AUTHORS
Neurology and neuromuscular diseasesPaedodonticsPredictive and prognostic markersTime-series analysisFamily and household studies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 08, 2026
Modeling the Budget Impact of Disease-Modifying Therapies in Infantile-Onset Spinal Muscular Atrophy.

|Jan 13, 2026
GuREx-MIH: cost-effectiveness analysis of extraction versus restorative treatment for first permanent molars affected by Molar-Incisor Hypomineralisation in 11-year-old Swedish children.

Adnan Hajdarević, Emina Čirgić, Birgitta Jälevik

|Jun 20, 2025
Reproducibility of published model-based cancer drug cost-effectiveness analyses: a study protocol for a cross-sectional analysis.

Mikael Svensson, Jonathan Siverskog, Naimi Johansson

|Apr 07, 2025
An analysis of US net cancer drug launch prices and clinical efficacy and certainty of evidence from 2008 to 2022.

Sumaya Abuloha, Benjamin P Harvey, Shu Niu

|Mar 25, 2024
A Review of the Cost-Effectiveness Evidence for FDA-Approved Cell and Gene Therapies.

Sumaya Abuloha, Shu Niu, Darlene Adirika

|Oct 16, 2023
The impact of stroke on spousal and family income: a difference-in-difference study from Swedish national registries.

Frida Labori, Josefine Persson, Mikael Svensson

Pageof 3

Frequent Collaborators

3 joint publications

Carl Bonander

3 joint publications

Frida Labori

2 joint publications

Josefine Persson

1 joint publications

Susanne Bernhardsson